CABALETTA BIO, INC. (CABA) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | -181.32M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $-181.32M | (m) |
| 2026-03-31 | (m) | $-175.43M | (m) |
| 2025-12-31 | (m) | $-167.86M | (m) |
| 2025-09-30 | (m) | $-158.52M | (m) |
| 2025-06-30 | (m) | $-144.29M | (m) |
| 2025-03-31 | (m) | $-126.76M | (m) |
| 2024-12-31 | (m) | $-115.86M | (m) |
| 2024-09-30 | (m) | $-104.16M | (m) |
| 2024-06-30 | (m) | $-89.98M | (m) |
| 2024-03-31 | (m) | $-76.87M | (m) |
| 2023-12-31 | (m) | $-67.67M | (m) |
| 2023-09-30 | (m) | $-62.48M | (m) |
| 2023-06-30 | (m) | $-57.46M | (m) |
| 2023-03-31 | (m) | $-55.88M | (m) |
| 2022-12-31 | (m) | $-52.98M | (m) |
| 2022-09-30 | (m) | $-51.17M | (m) |
| 2022-06-30 | (m) | $-51.30M | (m) |
| 2022-03-31 | (m) | $-49.53M | (m) |
| 2021-12-31 | (m) | $-46.29M | (m) |
| 2021-09-30 | (m) | $-41.71M | (m) |
| 2021-06-30 | (m) | $-38.54M | (m) |
| 2021-03-31 | (m) | $-35.56M | (m) |
| 2020-12-31 | (m) | $-33.34M | (m) |
| 2020-09-30 | (m) | $-29.43M | (m) |
| 2020-06-30 | (m) | $-25.69M | (m) |
| 2020-03-31 | (m) | $-20.90M | (m) |
| 2019-12-31 | (m) | $-16.94M | (m) |
| 2019-09-30 | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) |
| 2018-12-31 | (m) | $-12.20M | (m) |
| 2018-09-30 | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |